Vyne Therapeutics (VYNE) has had the highest return since August 16, 2025 by a US stock, returning 780,669.2%.
| ASSET | % RETURN |
|---|---|
Vyne Therapeutics (VYNE) | 780,669.23% |
Aptorum Group Ltd Class A (APM) | 600,614.29% |
WhiteHawk Minerals (WHK) | 435,733.33% |
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | 382,250% |
Seaport Therapeutics, Inc Common Stock (SPTX) | 242,100% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 4,164.29% |
AXT (AXTI) | 3,863.11% |
Sandisk (SNDK) | 3,608.72% |
Mega Fortune Company Limited Ordinary Shares (MGRT) | 3,077.14% |
CBL International Limited Ordinary Shares (BANL) | 1,550.81% |
Erasca (ERAS) | 1,101.31% |
New Era Energy & Digital (NUAI) | 1,052.27% |
Alto Neuroscience (ANRO) | 946.91% |
Damora Therapeutics (DMRA) | 843.47% |
Climb Bio (CLYM) | 728.93% |
Micron Technology (MU) | 701.99% |
Lumentum (LITE) | 695.31% |
Sellas Life Sciences (SLS) | 679.27% |
Praxis Precision Medicines (PRAX) | 677.8% |
Q32 Bio (QTTB) | 665.15% |
Shattuck Labs (STTK) | 657.14% |
Zenta (ZTG) | 655.38% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 652.84% |
Relmada Therapeutics (RLMD) | 642.92% |
Trinity Biotech (TRIB) | 633.5% |